|
null |
55 |
|
ecology, molecular virology, pathogenesis, sarscov-2 |
19 |
|
antivirals, biobank, covid-19, immunity, pathogenesis, viral characteristics |
17 |
|
drug discovery, mass spectrometry, medicine, metabolite, protoemics |
17 |
|
molecular imaging, positron emission tomography, pre-clinical, radiotracer |
16 |
|
big data, covid-19, international study, mental health, prognosis |
14 |
|
fighting disease recurrence, liver transplantation, promoting tissue repair |
14 |
|
cancer |
13 |
|
covid19, effectiveness, protection, sars-cov-2, vaccines, variants |
13 |
|
metabolic medicine |
13 |
|
biomarkers, cardiovascular, genomic, pluripotent |
11 |
|
coronavirus-2019, non-communicable diseases, service utilization, spill-over impact |
11 |
|
active surveillance, adverse events, covid-19, pharmacovigilance, safety, vaccines |
10 |
|
1) adhd 2) big data network 3) epidemiology 4) child cohort 5) data linkage |
10 |
|
molecular, multidisciplinary, pathology |
9 |
|
fear of cancer progression, metacognition approach , supportive-expressive approach, advanced cancer , randomized controlled trial |
9 |
|
aerosol generation, gastrointestinal endoscopy, transmissibility implications |
8 |
|
antihypertensive, big data, blood pressure target, hypertension, target trial emulation |
8 |
|
bone mineral density, fragility fracture, hip fracture, osteoporosis, primary fracture prevention, risk prediction |
8 |
|
cancer, cardiovscular risk factor, community-based, incidence, prevalence, risk engines |
8 |
|
antibiotic stewardship, cancer, chemotherapy, febrile neutropenia, randomised controlled |
8 |
|
hcc, ai , deep learning, microvascular invasion, medical imaging |
8 |
|
health technology assessment, real-world data and evidence, disease burden and care needs, cost-effectiveness evaluation, non-communicable diseases |
8 |
|
adipokines, adipose tissue inflammation, atherosclerosis, immunometabolism, macrophage polarization |
7 |
|
adipokines, disc degeneration, lumbar, spine |
7 |
|
asian screening array, diabetic complications, diabetic retinopathy, genome-wide association study, type 2 diabetes mellitus |
7 |
|
atypical femoral fracture, bisphosphonate, fracture, genotype-phenotype correlation, machine learning, osteoporosis |
7 |
|
cardiovascular disease, comorbidity, healthcare disparities, mortality, schizophrenia |
7 |
|
cardiovascular, lipid modifying drugs, risk prediction model |
7 |
|
climate change, ecology, environmental health, environmental science, forensics |
7 |
|
epstein-barr virus, genetic polymorphism, nasopharyngeal carcinoma, vitamin d |
7 |
|
hepatitis b |
7 |
|
refer to attachment |
7 |
|
acute generalized, adverse drug reaction, dress, incidence, severe cutaneous adverse, stevens johnson's |
6 |
|
adipokines, adipose tissue, cardiovascular diseases, metabolic syndrome, obesity |
6 |
|
adiponectin, diabetes, ischemic postconditioning, myocardial ischemia, stat-3 |
6 |
|
ai, ct, hcc, li-rads, liver cancer, machine learning |
6 |
|
anxiety, depression, meditation, parkinson's disease, yoga |
6 |
|
arterial stiffness, cardiovascular disease, genetic polymorphisms, mendelian randomization, mortality, vitamin d deficiency |
6 |
|
asymptomatic type 2 diabetics |
6 |
|
asymptomatic, cardiac, diabetics, empagliflozin, myocardial, resonance |
6 |
|
at risk group, chinese, diabetes, mobile app, prevention, validation |
6 |
|
behaviour, cognitions, environmental, genetic, risk perception, viral |
6 |
|
brief, exercise, instant messaging, lung cancer, physical activity |
6 |
|
cardiomyopathy, chinese, exome, mutations |
6 |
|
cardiovascular disease, coagulation, gegen, inflammation, lipids, pueraria |
6 |
|
case finding, diabetes mellitus, machine learning, pre-diabetes, primary care, risk prediction |
6 |
|
chronic hepatitis b, cirrhosis, fibrosis, metabolic, nucleoside analogue |
6 |
|
chronic hepatitis b, cost-effectiveness, disease progression, drug treatment, quality of life |
6 |
|
cirrhosis, hepatic steatosis, nafld, nash, sglt2 inhibitors |
6 |
|
complex disease, epidemiology, family history, genetic, risk profiling |
6 |
|
fatty, mobile health, non-alcoholic, non-alcoholic fatty liver disease, self-management, telemedicine |
6 |
|
healthy ageing |
6 |
|
mri compatible cycle ergometer |
6 |
|
emergency care, inflammation, mortality, pneumonia , prednisolone |
6 |
|
emergency room, advance care planning, end-of-life care, older adults and caregivers, motivational interviewing |
6 |
|
fracture, type 2 diabetes, secular trend, aspirin, angiotensin-converting enzyme inhibitors |
6 |
|
hepatocellular carcinoma, hepatectomy, liver transplantation, recurrence, biomarker |
6 |
|
hospitalization -associated, post-discharge care, geriatric patients, frailty, hospitalization |
6 |
|
myocardial infarction, atherosclerosis, glucagon-like peptide 1, surgery, |
6 |
|
prehabilitation, health education, lung cancer, functional capacity, cost-effectiveness |
6 |
|
ablation, fixed-dose, moderate-sized, multinodular, radioiodine-131, ultrasound |
5 |
|
adipokines, cardiovascular disease |
5 |
|
adipokines, diabetes, endothelium, obesity, vasodilation |
5 |
|
adiponectin, adrenomedullin, cardiovascular risk, hypertension, inflammation |
5 |
|
adipose, bone, glucose, insulin, sensitivity, tolerance |
5 |
|
adrenomedullin, human oviduct, inflammation, single nucleotide polymorphism, tubal ectopic pregnancy |
5 |
|
adverse drug reaction, agranulocytosis, genome-wide association, hyperthyroidism, pharmacogenetics |
5 |
|
adverse drug reactions, database, pharmacogenomics, stevens-johnson, toxic epidermal |
5 |
|
an artificial intelligence system, detection and characterization, early liver cancer |
5 |
|
an artificial intelligence system, early liver cancer, the detection and characterization |
5 |
|
analgesic, endothelin-1, neuropathic pain, pain, transgenic mice |
5 |
|
angiogram, artery, coronary, ct, disease, suspected |
5 |
|
antioxidant, blood brain barrier, matrix metalloproteinases, reactive nitrogen species, thrombolysos |
5 |
|
antioxidant, cardiac hypertrophy, diabetic cardiomyopathy, n-acetylcysteine, protein kinase c inhibition |
5 |
|
asian screening array, diabetic kidney disease, metabolite-genome-wide association study, metabolomics, type 2 diabetes |
5 |
|
attack rate, herd immunity, influenza, pandemic, seroprevalence, swine |
5 |
|
autophagy, caveolin-3, diabetes, ischemia |
5 |
|
baloxavir, flufenamic-acid, hospitalized, influenza, severe |
5 |
|
berberine, carcinoma, hepatocellular, metastasis, recurrence, tumour |
5 |
|
bisphosphonates, fracture, osteoporosis, pneumonia, zoledronate |
5 |
|
blind, celecoxib, infection, influenza, severe, treatment |
5 |
|
breast cancer |
5 |
|
cancer, cylcotron, molecular imaging, neurology, positron emission tomography |
5 |
|
cardiac, free, mrt, patients, poor, sick |
5 |
|
cardiovascular diseases, drug screening, pluripotent human stem cell, tissue regeneration |
5 |
|
chemical biology, mass cytometry, metallomics, metal-tagged antibody, single cell |
5 |
|
chinese, complications, cvd, dm, mortality, risk |
5 |
|
chronic hepatitis b infection, cirrhosis, empagliflozin, fibrosis, sglt2 inhibitors |
5 |
|
chronic hepatitis b, disease monitoring, risk stratification, serum quantitative, surface antigen measurements |
5 |
|
chronic hepatitis b, donor, hbv dna, hepatitis b reactivation, hsct, recipient |
5 |
|
chronic hepatitis b, epigenetics, hbv replication, hepatitis b virus, protein structure, viral protein |
5 |
|
circulating biomarkers, inflammation and tumour recurrence, liver transplantation, marginal graft injury, tissue repair by stem cells |
5 |
|
cirrhosis, diabetes, hepatitis b, liver fibrosis, nucleoside analogue, transient elastography |
5 |
|
cirrhosis, functional cure, hepatitis b, liver fibrosis, liver stiffness, transient elastograph |
5 |
|
cognitive behaviour therapy, mobile intervention, psychological well-being, rct, stroke caregiver |
5 |
|
cognitive–behavioural therapy, depression, early psychological intervention, ecological momentary intervention, instant messaging, stroke caregiver |
5 |
|
cohort study, elderly, healthy ageing, mastication, oral health, quality of life |
5 |
|
colorectal cancer, discrete choice experiment, low-dose aspirin, pharmacoeconomics, preferences |
5 |
|
community-based, management patterns, morbidity, primary care services |
5 |
|
controlled trial, health promotion, healthy ageing |
5 |
|
corneal epithelial stem cell, corneal-limbal epithelium, induced pluripotent stem cells, limbak stem cell deficiency, regeneration |
5 |
|
coronary heart disease, hong kong |
5 |
|
depressive disorders, primary care |
5 |
|
diabetes, energy homeostasis, hormones, metabolic regulation, obesity |
5 |
|
diabetes, inducible nitric oxide synthas, ischemia-reperfusion, myocardial preservation, postconditioning |
5 |
|
diabetes, ischemic preconditioning, myocardial reperfusion, non inasive ipc |
5 |
|
diabetic retinopathy, genetic variants, genetics, type 2 diabetes |
5 |
|
dialyzed, hbv, imiquimod, intradermal, vaccination |
5 |
|
epigenetic analysis, genetic analysis, occult hepatitis b infection |
5 |
|
family doctor, health care, utilization pattern |
5 |
|
fracture, osteoporosis, ppis, proton pump inhibitors |
5 |
|
glycaemic control, rct, smoking cessation, type 2 diabetes |
5 |
|
haemagglutination inhibition, microneedly device (micronjet), swine origin influenza virus vaccine |
5 |
|
influenza, innate immunity, pandemic, severe, single nucleotide polymorphism |
5 |
|
leukotriene b4, ltb4 12-hydroxydehydrogenase, molecular mechanism, myocardial infarction, neutrophils |
5 |
|
macrolide, mycoplasma, resistance |
5 |
|
noise, noise sensitivity, non-restorative sleep, sleep |
5 |
|
suspension antibody |
5 |
|
therapeutic efficacy |
5 |
|
1) magnetic resonance imaging 2) resting-state fmri 3) brain networks 4)
optogenetics 5) neuromodulation
|
5 |
|
1) systemic lupus erythematosus 2) genomic medicine 3) clinical subphenotype mapping |
5 |
|
berberine, trial, chinese medicine, lipoprotein |
5 |
|
influenza vaccine, topical imiquimod, non-responsiveness, seroconversion rate, children |
5 |
|
institutionalised elders , denture plaque, metagenomic sequencing, respiratory pathogens |
5 |
|
ivabradine, atrial fibrillation, rate control, drug repositioning, inflammation |
5 |
|
lipid-lowering agents, inclisiran, pcsk9 inhibitors, evolocumab, alirocumab |
5 |
|
lung cancer, aerobic exercise, tai-chi, symptom cluster , mediating pathway |
5 |
|
multimorbidity clusters, dementia, mortatlity , electronic health records, multinational cohort study |
5 |
|
multiplex polymerase, point-of-care testing, rapid diagnostic test, respiratory infections, emergency department |
5 |
|
vaccine hesitancy, attitude roots, chronic disease, vaccine communication, respiratory infection |
5 |
|
walking exercise, exercise guidelines, exercise prescription, liver fat, obesity |
5 |
|
acute myeloid leukaemia, c-kit, prognosis |
4 |
|
acute myeloid leukaemia, personalized and innovative treatment |
4 |
|
acute myocardial infarction, arachidonic acid metabolism, macrophage polarization, molecular mechanism, pyruvate kinase m2 |
4 |
|
adipokine, biomarker, cardiovascular disease, obesity-susceptibility genes, the metabolic syndrome |
4 |
|
adiponectin, diabetes, foxo1, ischemia reperfusion, postconditioning |
4 |
|
advance care planning, cluster, end of life care, intervention, pragmatic, residential care home |
4 |
|
aerosol genderating procedures, covid-19, dental aerosols, mouthwashes, respiratory pathogens |
4 |
|
affected, pollution, prognosis, severity, stroke, subtypes |
4 |
|
age period cohort, china, ischemic heart disease, projections |
4 |
|
aging, ischemia/reperfusion injury, p53, pgc1α, rap1 |
4 |
|
airway inflammation, bronchiectasis, clinical trial, roflumilast |
4 |
|
aliskiren, diabetes mellitus, diabetic cardiomyopathy, myocardial fibrosis |
4 |
|
alzheimer's disease, antihypertensive, big data, dementia, epidemiology |
4 |
|
alzheimer’s disease, bisphosphonates, dementia, osteoporosis, pharmacoepidemiology, real-world |
4 |
|
aml, rq-pcr, t(8;21) |
4 |
|
antibody, avian, h5n1, h7n9, influenza, seroprevalence |
4 |
|
anticoagulation, bleed, cohort, dabigatran, ulcer |
4 |
|
as-apex, diagnostics, hepatitis, microarray |
4 |
|
attenuated, controlled, identification, measurements, parameter, provision |
4 |
|
biofilm, dental caries, prebiotics, probiotics, synbiotics |
4 |
|
biomarkers, genetics, precision treatment, syngr1, systemic lupus erythematosus |
4 |
|
blood donation, blood screening, infectivity, nucleic acid test, occult hepatitis b infection |
4 |
|
bone density, bone turnover, diabetes, statin, trabecular bone score |
4 |
|
bone mineral density, cardiovascular disease, epidemiology, interaction, prospective, vitamin d |
4 |
|
bone mineral density, chromosome, osteoporosis |
4 |
|
bowel disease, inflammatory, magnetic resonance enterography, patients |
4 |
|
breast cancer, patient derived xenografts, potential targeted treatment, testing ivabradine |
4 |
|
cancer, chemopreventive, colorectal, epidemiology, interval, prognosis |
4 |
|
cardiac magnetic, diastolic dysfunction, heart failure with, strain, tissue tracking |
4 |
|
cardiovascular disease, chinese medicine celastrol, molecular mechanism, obesity, pyruvate kinase m2 |
4 |
|
cardiovascular disease, diabetes, endothelial dysfunction, obesity, vascular inflammation |
4 |
|
caries prevention, fluoride varnish, randomized controlled trial, sjogren's syndrome |
4 |
|
caveolin-3, diabetes, ischemic postconditioning, myocardial ischemia, pkc-ϵ |
4 |
|
cd36, ischemia/reperfusion injury, pparα, rap1, type 2 diabetes |
4 |
|
chaperone grp78, chinese medicine celastrol, er stress, molecular mechanism, obesity |
4 |
|
chemical proteomics, epigenetics, histone modification, posttranslational modification |
4 |
|
chinese medicine, sleep disorder, stroke |
4 |
|
chondrocyte, degeneration, fatty aicd binding protein, macrophage polarization, osteoarthritis |
4 |
|
chronic hepatitis b |
4 |
|
cirrhosis, diagnosis, fibrosis, liver, non-invasive, serum |
4 |
|
clarithromycin, flufenamic acid, hosptialised, influenza, oseltarmivir |
4 |
|
clinical trials centre, healthcare, education and life sciences research and development, queen mary hospital |
4 |
|
consumer health informatics, disease self-monitoring, health behavior adoption, human factors engineering |
4 |
|
diabetes, diabetic, exploring, microrna, retinopathy, sight-threatening |
4 |
|
diabetes, ischemia reperfusion, postconditioning, sevoflurane |
4 |
|
double-blind, hsct, intradermal, randomized, vzvv |
4 |
|
dyadic intervention, family care, health-related quality of life, heart failure, hospital readmission, self-care |
4 |
|
dysfunction, endothelial, human, prostacyclin, receptors |
4 |
|
economic evaluation, end-stafe renal disease, haemodialysis, markov model, peritoneal dialysis, renal replacement |
4 |
|
effects, mushroom, ostreatus, oyster, pleurotus, protective |
4 |
|
endothelial dysfunction, hypertension, lipocalin-2 |
4 |
|
epidemiology, fine needle aspiration, incidentaloma, thyroid carcinoma, thyroid nodule, ultrasonography |
4 |
|
erythematosus |
4 |
|
exercise training, fatty liver, hiit, metabolic syndrome, obesity |
4 |
|
flu-based, pd1-based vaccines |
4 |
|
functional imaging, lymphoma, positron emission tomography, prognostication, response assessment |
4 |
|
graves' disease, high-intensity focused, minimally invasive, radioactive iodine, thyrotoxicosis, ultrasound |
4 |
|
heart failure, myocardial infarction, spinal cord stimulation |
4 |
|
hydroxychloroquine, interferon, randomized controlled |
4 |
|
hyperglycemia, insulin resistance, metabolic hormones, obesity, type 2 diabetes |
4 |
|
hyperimmune convalescent plasma, randomised double-blind, swine origin influenza virus, treatment of s-oib h1n1 infection |
4 |
|
impairment, perspective, plausible, underpinning, vessel, wiring |
4 |
|
intracerebral hemorrhage, magnetic resonance imaging, nanotechnology, pathophysiological mechanisms, renovascular hypertension |
4 |
|
intracerebral hemorrhage, vitamin d |
4 |
|
iron overload |
4 |
|
liver cancer |
4 |
|
liver transplantation, marginal graft injury, recurrence and metastasis, surgical stress, tumor microenvironment |
4 |
|
low/intermediate-1, myelofibrosis, myeloproliferative neoplasm, pre-fibrotic, ropeginterferon alfa-2b, the ropeg-mf |
4 |
|
lung cancer |
4 |
|
noninvasive method |
4 |
|
population health survey |
4 |
|
sepsis, sodium glucose, sglt2 inhibitor, intensive care unit, septic shock |
4 |
|
stroke caregivers |
4 |
|
advance care planning, dementia, end-of-life care, palliative care, alzheimer's dementia |
4 |
|
alcohol, drinking, liver, hepatitis, cirrhosis |
4 |
|
covid-19, neutralizing antibody, t cell immunity, geriatrics, vaccine |
4 |
|
dementia, feeding, hospital readmissions, randomized controlled, home care |
4 |
|
long covid, endocrinology , metabolism, bone, diabetes |
4 |
|
mafld, diabetes, cardiovascular disease, liver fibrosis, population-based study
|
4 |
|
oral anticoagulants, atrial fibrillation, mitral stenosis, electronic health records, |
4 |
|
physical inactivity, children and adolescents, life course, early life, non-communicable |
4 |
|
rhythm control medications, rate control medications, sglt2 inhibitors, atrial fibrillation, mitral stenosis |
4 |
|
shared decision-making, goals-of-care discussions, doctor-patient communication, chronic kidney disease, older adults |
4 |
|
stroke, caregiver, insomnia, sleep, cognitive behavioral therapy |
4 |
|
systemic lupus erythematosus, genetics, patient stratification, risk prediction, precision treatment |
4 |
|
tirzepatide, semaglutide, obesity, type 1 diabetes, cardiovascular risk |
4 |
|
15-keto-prostaglandin f2α, arachidonic acid, macrophage polarization, myocardial ischemia-reperfusion injury, pyruvate kinase m2 (pkm2) |
3 |
|
a-fabp neutralizing monoclonal antibody, ischemic stroke treatment |
3 |
|
a-fabp, diabetic cardiomyopathy, endothelial dysfunction, inflammation, oxidative stress |
3 |
|
abacavir, cardiovascular events, endothelium |
3 |
|
acetate, gut microbiota, inflammation, lps, lupus nephritis, short chain fatty acids |
3 |
|
acid, binding, fatty, osa, protein |
3 |
|
acute myeloid leukemia, drug screening, monocarboxylate transporter, patient samples, single cell transcriptome |
3 |
|
acute promyelocytic leukaemia, fms-like tyrosine kinase 3 internal tandem duplication, oral arsenic trioxide, relapse |
3 |
|
acute promyelocytic leukaemia, oral arsenic trioxide, resistance |
3 |
|
adhd, blood glucose control, gestational diabetes, maternal diabetes mellitus, paediatrics |
3 |
|
adipocyte fatty acid binding protein, fatty liver, obesity |
3 |
|
adipocyte fatty acid, biomarker, diabetes mellitus, diabetic retinopathy, sight threatening |
3 |
|
adipocyte fatty acid, diabetes, vascular |
3 |
|
adiponectin, adiporon, agonist, molecule, potential, receptor |
3 |
|
adiponectin, animal, gene, investigation, model, therapy |
3 |
|
adiponectin, cardiac transplantation, grafts rejection, immune regulation, ppar-gamma |
3 |
|
adipose tissue, ep4 receptor, inflammation, obesity, prostaglandin e2 |
3 |
|
adolescent, gene, idiopathic scoliosis |
3 |
|
adp-ribosyl cyclase, calcium signaling, cd38, cyclic adp-ribose, protein crystal structure |
3 |
|
adrenomedullin |
3 |
|
adverse events, copd, medication safety, mental health, neuropsychiatric events, roflumilast |
3 |
|
ageing |
3 |
|
ageing, directed evolution, neural stem cells, protein engineering, reprogramming, transdifferentiation |
3 |
|
agonist, alzheimer’s, apelin, disease, receptor, therapeutic |
3 |
|
akap11, bone mineral density, mineralization, osteogenesis, osteoporosis, sequencing |
3 |
|
alveolar bone loss, animal experimentation, exercise, metabolic diseases, obesity |
3 |
|
analytics, colorectal cancer, fecal immunochemical test, prediction, screening |
3 |
|
anaplastic lymphoma kinase, non-small cell lung cancer |
3 |
|
androgen excess, antral follicle count, early atherosclerosis, metabolic syndrome, non-alcoholic fatty liver disease, polycystic ovary syndrome |
3 |
|
angiography, computed, coronary, free, poor, tomography |
3 |
|
anitviral therapy, hbv dna integration, hepatitis b virus, hepatocyte clonal expansion, inverse pcr |
3 |
|
ankylosing spondylitis, eq-5d, health related quality of life, spondyloarthritis |
3 |
|
antibody, cardiovascular, development, discovery, innovative, metabolic |
3 |
|
anticoagulation therapy, discrete choice experiment, medical-decisions, stroke prophylaxis, willingness-to-pay |
3 |
|
antithyroid, genetic, prescribing, screening, service |
3 |
|
apob gene, cascade genetic screening, dutch lipid clinic network criteria, familial hypercholesterolemia, ldlr gene, pcsk9 gene |
3 |
|
artificial intelligence (ai), personalised community stroke rehabilitation |
3 |
|
artificial intelligence, novel lossless medical image compression |
3 |
|
association, bioinformatics, candidate gene, genetics, osteoporosis |
3 |
|
association, bone mineral density, chinese, genes, osteoporosis |
3 |
|
asymptomatic, flavivirus, infection, prevalence, virs, zika |
3 |
|
atherogenesis, endothelial dysfunction, osa |
3 |
|
atherosclerosis, diabetes, phosphorylation, proteomics, vasodilation |
3 |
|
atherosclerosis, endothelial cells, senescence |
3 |
|
atherosclerotic cerebrovascular, cardiovascular disease, guangzhou |
3 |
|
autophage dysfunction, cardiomyopathy, danon disease, patient-specific ipscs, x-linked disorders |
3 |
|
axonal injury, retinal ganglion cells, telomerase |
3 |
|
b cell signatures, clinical flares, immunosuppression, lupus nephritis, pre-emptive treatment |
3 |
|
b lymphocytes, cardiovascular diseases, cholesterol metabolism, hypercholesterolemia |
3 |
|
baicalin, cachexia, hepatocellular carcinoma, interleukin-6 |
3 |
|
bendamustine, chronic lymphocytic leukemia, non-hodgkin lymphoma |
3 |
|
bio-artificial pacemaker, gene therapy, long-term efficacy, pacemaker ion channels, sick sinus syndrome |
3 |
|
bioengineering, heart failure, human embryonic stem cell, proarrhythmia, transplantation |
3 |
|
bioinformatics model, gene regulation, head & neck cancer progression, regulatory genomic variants, transcription factor |
3 |
|
biological comparison |
3 |
|
biomarkers, colorectal cancer, methylated dna, plasma |
3 |
|
biomedical imaging, iron metabolism, mri, thalassemia, tissue iron overload |
3 |
|
blepharospasm, botulinum toxin, cost effectiveness, dystonia, hemifacial spasm, quality of life |
3 |
|
blood brain barrier, hemorrhagic transformation, hyperglycemia, ischemic stroke, peroxynitrite |
3 |
|
bmd, bone mineral density, osteoporosis |
3 |
|
bone marrow cells transplantation, ischemic myocardium, neovascularization |
3 |
|
bone marrow, cell proliferation, ionic channels, stem cells |
3 |
|
bone mineral density, chinese, chromosome, genes, osteoporosis |
3 |
|
calcium signals, cell proliferation, heart failure, human cardiac fibroblast |
3 |
|
calcium, ion channel, stem cell |
3 |
|
cancer, immunotherapy, liver, lung, meta-analysis, translational |
3 |
|
cardiac function, congenital heart disease, gut microbiome, heart-liver-gut axis |
3 |
|
cardiac repair, cardiomyocyte, induced pluripotent stem cells, swine |
3 |
|
cardiac stress, computed tomography, coronary angiography, coronary artery disease, coronary computed |
3 |
|
cardiac, diabetes, myocardial preservation, opioid, remifentanil |
3 |
|
cardiac, familial, laminopathy, medicine, precision, towards |
3 |
|
cardiovascular diseases, fabp4, metabolic syndrome |
3 |
|
cardiovascular diseases, good manufacturing practice, heart failure, induced pluripotent stem cell, mesenchymal stem cell |
3 |
|
cardiovascular diseases, hif, obesity |
3 |
|
cardiovascular magnetic resonance, coronavirus disease 2019, covid-19, myocardial inflammation |
3 |
|
cardiovascular, risk factor |
3 |
|
cd36, diabetic cardiomyopathy, ep4, fatty acid metabolism, foxo1 |
3 |
|
cell, discovery, hyperlipidemia, platform, pluripotent, stem |
3 |
|
cellular cholesterol efflux, cholesterol transporters |
3 |
|
cfi-400945, hepatocellular carcinoma, phase 1, polo-like kinase 4 inhibitor |
3 |
|
childhood, conjugate, immunisation, interrupted, pneumococcal, pneumonia |
3 |
|
chinese, diabetes mellitus, genetics, single nucleotide polymorphisms (snp) |
3 |
|
chloride channels, cystic fibrosis, potassium channels, self-assembly, synthetic ion channels |
3 |
|
chromatin immunoprecipitation, chronic hepatitis b, hbv replication, hbv transcription, hepatitis core protein, mutagenesis |
3 |
|
chronic inflammation, hba1c, oral health, periodontal disease, randomized controlled trial, type 2 diabetes |
3 |
|
chronic kidney disease, esrd, glomerular filtration, masticatory dysfunction, nutritional status, type 2 diabetes |
3 |
|
chronic, elderly, imiquimod, influenza, intradermal, vaccne |
3 |
|
clinical trials, novel pharmaceutical products, pharmacodynamics trials, pharmacokinetics trials, phase 1 trials, phase 2 trials |
3 |
|
clofarabine |
3 |
|
cognition, neurocognitive, obstructive sleep apnea, psychosocial, quality of life, sleep |
3 |
|
collaboration dynamics, daily stressor, ecological momentary assessmen, functional decline, spousal interdependence |
3 |
|
comprehensive, encephalitis, investigations |
3 |
|
consumer health, diabetes mellitus and, randomized controlled, self-monitoring |
3 |
|
continous positive airway pressure, education, obstructive sleep apnea |
3 |
|
crohn's disease, influenza, ulcerative colitis, vaccine |
3 |
|
cytokines, immunosuppressive, lupus nephritis, lymphocyte subsets, relapse |
3 |
|
demethylating agents, flt3 mutation, myelodysplastic syndrome, secondary aml |
3 |
|
demyelination, lesion detection, mri, ms, multiple sclerosis, neurological disease |
3 |
|
dendritic cell functions, ex vivo, thalassaemia patients, uner iron overload conditions |
3 |
|
dendrobium officinale, diabetic, nephropathy, pharmacological effect, yuye decoction (doy) |
3 |
|
detect silent brain, elderly, novel cardiac imaging technique, subsequent vascular dementia |
3 |
|
determination, myelofibrosis, novel, patients, prognosis, using |
3 |
|
diffusion tensor imaging, dti, heart, magnetic resonance imaging, mri |
3 |
|
disease modeling, drug screening, friedreich ataxia, induced pluripotent stem cells |
3 |
|
dopaminergic neurons, environmental toxin, lrrk2, mitochondria, parkinson's disease, synaptic dysfunction |
3 |
|
dry powder inhaler formulation, inhaled nanoparticles, lung cancer, pulmonary drug delivery |
3 |
|
electrical impedance tomography, fatty liver disease |
3 |
|
endomyocardial injection, end-stage |
3 |
|
exercise intervention, hiit, interval training, metabolic syndrome, obesity |
3 |
|
exhaustion, immunosuppression, lupus nephritis, memory b cells, relapse |
3 |
|
fenofibrate, ppar, sjogren’s syndrome, syndrome, targeting, treatment |
3 |
|
genetic susceptibility, humoral immunity, subphenotypes, systeemic lupus erythematosus, taci |
3 |
|
genotype, hepatitis-analysis, hepatocellular carcinoma |
3 |
|
hepatocellular carcinoma, metastasis, p53, pin1 |
3 |
|
hormonal replacement therapy, hypogonadol men, ment ac |
3 |
|
invasion, metastasis, pin1, rhoa |
3 |
|
ischemic stroke, magnetic resonance imaging (mri), queen mary hospital, transient ischemic attack |
3 |
|
kidney disease, rapamycin, systemic lupus erythematosus |
3 |
|
kidney transplant, serum polyoma bk virus |
3 |
|
klf4, mesenchymal stem cell ageing, mitochondrial biogenesis, mitochondrial dynamics, mitochondrial dysfunction |
3 |
|
leukaemia, lymphoma |
3 |
|
liver cancer, pin1, survivin |
3 |
|
liver graft injury, liver transplantation |
3 |
|
liver stiffness, tricuspid annulopasty, tricuspid regurgitation |
3 |
|
locomotion, motor phenotype, parkinson’s disease, symptom asymmetry, visual cues, visuospatial impairment |
3 |
|
lupus, mycophenolic acid, nephritis, pharmacogenomics, pharmacokinetics |
3 |
|
matrix g1a protein, osteogenic epcs, rheumatoid arthritis, vascular calcification, vitamin k |
3 |
|
mechanobiology of obesity |
3 |
|
medicine |
3 |
|
nk-cell lymphomas, pd-1 blockade with pembrolizumab, relapsed/refractory mature t-cell |
3 |
|
obstructive sleep apnoea |
3 |
|
oral appliances, quality of life, sleep apnoea |
3 |
|
sars |
3 |
|
sleep apnoea |
3 |
|
- |
3 |
|
ambivalence, decision making, family carers, dementia, biopsychosocial model |
3 |
|
bioinorganic chemistry, metalloproteomics, mechanism, arsenic trioxide, metallodrug |
3 |
|
blood volume, normovolemia, cardiac filling, stroke volume, frank-starling |
3 |
|
dysregulated host, gut microbiota |
3 |
|
inborn errors of immunity, immunodeficiency, stat1 , gain-of-function, expanded potential stem cell |
3 |
|
l-arginine, type 2 diabetes, prediction, glucose metabolism, insulin secretion |
3 |
|
metabolic syndrome, drug repositioning, clinical trial, empagliflozin, adipokine |
3 |
|
microscopy, cell-based assay, imaging cytometry |
3 |
|
nanoparticles, nose-to-brain delivery, alzheimer's disease, spray drying
|
3 |
|
open-label, randomized, trial, inhaled, remdesivir |
3 |
|
osteogenesis imperfecta, health technology, cutting-edge therapies, cost-effectiveness
|
3 |
|
point-of-care test, micro-elimination, prison health, outreach team, portable fibroscan |
3 |
|
quantitative stress cardiac magnetic resonance, myocardial blood flow, myocardial perfusion reserve, vericiguat, coronary microvascular dysfunction |
3 |
|
randomized controlled trial, green prescription, ikigai, depression, older adults living alone |
3 |
|
xldcm, bmd, ipsc disease model, epigenetics, hdac inhibitors |
3 |
|
1) arsenic, anti-leukaemia, icp-ms, metallomics and metalloproteom, proteins |
2 |
|
4-methylumbelliferone, hyaluronan, inflammation, lupus nephritis |
2 |
|
6q22.33-q23.2, nasal lymphoma, nk-cell lymphoma, ptprk, tumor suppressor |
2 |
|
absolute fracture risk, cost-effectiveness analysis, hong kong chinese, intervention thresholds, osteoporosis |
2 |
|
acacetin |
2 |
|
acetate, kidney fibrosis, kidney inflammation, lupus nephritis, short chain fatty acids |
2 |
|
acetylcholine receptor, actin, adf/cofilin, endocytosis, myasthenia gravis, neuromuscular junction |
2 |
|
acid, adipocyte, binding, fatty, pathological, protein |
2 |
|
acid, atherosclerosis, fatty, immunity, microbiota, therapeutic |
2 |
|
acute myeloid leukaemia, aquaglyceroporin 9, arsenic trioxide, azacytidine |
2 |
|
acute myeloid leukemia |
2 |
|
acute promyeloyctic leukaemia, arsenic trioxide, asia, outcome |
2 |
|
adaptive thermogenesis, adipocyte biology, energy homeostasis, metabolism, obesity |
2 |
|
adaptive thermogenesis, adipokines, brown adipocytes, energy homeostasis, obesity |
2 |
|
adaptive thermogenesis, adipose tissue browning, neutrophil elastase (ne), obesity, proteinase 3 (pr3) |
2 |
|
adaptive thermogenesis, adipose tissue, posttranscriptional regulation, toll-like receptor 5, uncoupling protein-1 |
2 |
|
adenosine, cardioprotection, ischemia, nucleoside transporters |
2 |
|
adipocyte fatty acid, alcoholic steatohepatitis, fibrosis, non-alcoholic, steatosis |
2 |
|
adipocyte fatty acid, mediator, obesity-related medical complications, protein |
2 |
|
adipogenesis, mechano-sensitive, obesity, piezo1, thermogenesis |
2 |
|
adipokine, depression, glucocorticoid, hippocampus, neurogenesis, physical exercise |
2 |
|
adipokine, fatty liver, inflammation, metabolic syndrome, obesity |
2 |
|
adipokine, inflammation, insulin resistance, obesity |
2 |
|
adipokine, inflammation, lipocalin-2, metabolic syndrome, obesity |
2 |
|
adipokines, adipose tissue inflammation, gut microbiota, insulin resistance, obesity |
2 |
|
adipokines, adipose tissue, biomarker, insulin resistance, risk factor, type 2 diabetes |
2 |
|
adipokines, adipose tissues, energy expenditure, metabolic diseases, obesity |
2 |
|
adipokines, atherosclerosis, inflammation, jnk, obesity |
2 |
|
adiponectin modules, efficacy, immunotherapeutic amyloid clearance |
2 |
|
adiponectin, adiporon, alzheimer's disease, cerebral insulin resistance, neurodegeneration, tau |
2 |
|
adiponectin, airway, cigarette smoke, inflammation, oxidative stress |
2 |
|
adiponectin, anti-atherogenic, anti-diabetic |
2 |
|
adiponectin, diabetes |
2 |
|
adiponectin, fatty liver disease, inflammation, metabolic syndrome, obesity |
2 |
|
adipose tissue, adrenomedullin, insulin resistance, metabolism, muscles |
2 |
|
adipose tissue, liposomes, microneedles, obesity, thyroid hormone |
2 |
|
adverse events of special, cohort study, comirnaty, coronavac, covid-19 |
2 |
|
afabp, endothelial dysfunction, enos, ros, tf |
2 |
|
airway injury, copd, mesenchymal stem cells, mitochondrial transfer, oxidative stress |
2 |
|
akt signalling pathway, high-fat diet, metabolic diseases, methyl donor, non-alcoholic fatty, prmt1 |
2 |
|
aldosterone, angiotensin, igan, mesangial cells, tgf-beta |
2 |
|
alemtuzumab, anti-cd52, chemotherapy, leukemia |
2 |
|
all-trans retinoic acid, haematopoietic stem cell, stromal cells |
2 |
|
allele screening, allopurinol-induced, chronic kidney disease, cutaneous reactions, hla-b* |
2 |
|
allergy, asthma, gene, polymorphisms |
2 |
|
alpha-synuclein, glucocerebrosidase mutation, lysosomal degradation, parkinson's disease, protein aggregation |
2 |
|
alpha-synuclein, lrrk2, misfolded protein, neurotoxicity, oligomers, parkinson's disease |
2 |
|
amyotrophic lateral sclerosis, chromosome 8q24 |
2 |
|
and secondary acute myeloid leukaemia (aml) in asia, clinical and genomic registry, myelodysplastic syndrome (mids) |
2 |
|
angiogenesis, hepatoma, metastasis, pin1, tumour invasion |
2 |
|
angiopoietin-like protein 4 |
2 |
|
angiotensin ii, apoptosis, iga nephropathy, pathophysiology, podocyte injury |
2 |
|
angiotensin receptor blocker, aortic stenosis, left ventricular remodeling |
2 |
|
angptl4, diabetes, genetics |
2 |
|
animal models, inflammation and fibrosis, mesenchymal stem cells, proteinuria, renal tubular cell |
2 |
|
ankylosis, biologics, dose reduction, mri, rct, spondyloarthritis |
2 |
|
annexin ii, anti-dna antibodies, inflammation, lupus nephritis |
2 |
|
annexin ii, fibrosis, inflammation, lupus nephritis, mesangial cells |
2 |
|
antagonist, anticoagulants, free, non-vitamin, oral, provision |
2 |
|
anti-cd20, chronic, leukaemia, lymphocytic, monoclonal, obinutuzumab |
2 |
|
anti-dna antibodies, lupus nephritis, mesangial cells |
2 |
|
anti-dsdna antibodies, fibronectin, fibrosis, inflammation, lupus nephritis |
2 |
|
anti-dsdna antibodies, fibrosis, inflammation, ku70/80, lupus nephritis |
2 |
|
anti-dsdna antibodies, inflammation, lupus nephritis, major vault protein, tubulo-interstitial injury |
2 |
|
anti-dsdna antibodies, inflammation, lupus nephritis, renal tubular epithelial cells |
2 |
|
anti-tumor, cyclooxygenase-2 |
2 |
|
antibiotic, infection, pathogens, rapid, respiratory, tract |
2 |
|
antibody therapeutics, biomarker, hepatokines, metabolic liver disease, metabolic syndrome, nonalcoholic steatohepatitis |
2 |
|
antibody, anti-phospholipase, idiopathic, membranous, nephropathy, receptor |
2 |
|
aortic dissection, endovascular stent graft |
2 |
|
apoptosis, cigarette smoking, endothelial dysfunction, intermittent hypoxia, obstructive sleep apnea |
2 |
|
apoptosis, glomerulosclerosis, iga nephropathy, podocytes, renin-angiotensin system |
2 |
|
apoptosis, inflammation, myocardial i/r injury, nlrp3, rap1, stat3 |
2 |
|
aquaporin-4, autoantibodies, autoimmunity, neuroinflammation, neuromyelitis optica, pioglitazone |
2 |
|
arginase, biomarkers, pegylated, predictive, recombinant, therapeutic |
2 |
|
arsenic trioxide, bcl6, lymphoma |
2 |
|
arthritis, biologic, herpes zoster, inflammatory, therapies, vaccine |
2 |
|
artificial intelligence, body constitution types, pulse patterns, traditional chinese medicine |
2 |
|
asia, mds, ngs |
2 |
|
astragalus, chinese medicine, clinical trial, diabetic nephropathy, integrative medicine, predictive analysis |
2 |
|
atherosclerosis, biomarkers, cardiovascular disease, inflammation, neutrophils |
2 |
|
atherosclerosis, flagellin, gut microbiota, hdl, lipoproteins, tlr5 |
2 |
|
atp, mitochondria, oxidative stress, parkinson's disease, uncoupling proteins |
2 |
|
atrial fibrillation, atrial function, atrial mechanical dyssynchrony, different pacing modes, sinus node disease |
2 |
|
atrial fibrillation, dabigatran, mitral stenosis, new oral anticoagulants, prevention, warfarin |
2 |
|
autoantibody, burkholderiosis, immunodeficiency, interferon gamma, non-tuberculous mycobacteriosis, non-typhoidal salmonellosis |
2 |
|
autocrine |
2 |
|
autoimmunity, cell biology, c-type lectin receptor, dendritic cells, systemic lupus erythematosus |
2 |
|
autologous, bortezomib, consolidation, multiple, myeloma, transplantation |
2 |
|
autologous, bortezomib, myeloma, transplantation |
2 |
|
autophagic cardiomyopathy, danon disease, ipscs- and animal-based model, lamp2 mutation, modified rna |
2 |
|
autophagic, defective, mitochondria, mitophagy, parkinson's, therapeutic |
2 |
|
autophagy, endoplasmic reticulum stress, fatty acid binding protein, inflammation, obesity related diseases |
2 |
|
autotaxin, complications, mediator, metabolic, obesity-related, potential |
2 |
|
azacitidine, high-risk, myelodysplastic, patient, provision, syndrome |
2 |
|
b-type, free, natriuretic, peptide, provision, testing |
2 |
|
balloon-assisted, bowel, capsule, diseases, endoscop, enteroscopy |
2 |
|
beers' criteria, elderly, inappropriate prescribing, stopp/start criteria |
2 |
|
beta klotho, diabetes, erk1/2 pathway |
2 |
|
bioresorbable vascular, coronary bifurcation, drug coated balloon, side branch |
2 |
|
birth defects, pax 6 |
2 |
|
blood cancers, stem cell transplantation |
2 |
|
blood pressure, cerebral small vessel disease, stroke |
2 |
|
blys, gene polymorphisms, systemic lupus erythematosus |
2 |
|
bmp, deregulated haematopoiesis, zebrafish |
2 |
|
bmt, herpes zoster cellular, live-attenuated varicella |
2 |
|
body temperature, infrared thermography, sars |
2 |
|
bone marrow, differentiation propensity, heart protection, human embryonic stem cells, mescenchymal stem cells, term placenta |
2 |
|
bone mineral density, chinese, chromosome 1q, osteoporosis, susceptibility genes |
2 |
|
brain volume loss, diffusion kurtosis, magnetic resonance, multiple sclerosis, myo-inositol, neuromyelitis optica |
2 |
|
bronchiectasis |
2 |
|
bronchiectasis, inhaled fluticasone |
2 |
|
brown adipose tissue, endothelial dysfunction, obesity, perivascular adipose, sirt1 |
2 |
|
c/ebp-epsilon, differentiation, dna methylation, enhancer, mll-rearranged leukemia |
2 |
|
cad, dyssynchrony, echocardiogram, exercise-induced |
2 |
|
calprotection, diagnosis, fecal, monitoring, patients, use |
2 |
|
cancer, colon, emt, fhl2, metastasis |
2 |
|
cancers, oral arsenic, trioxide |
2 |
|
capd, ctgf, peritoneal membrane dysfunction |
2 |
|
carcinogenesis |
2 |
|
cardiac c-kit+ cells, cell migration, ion channels, proliferation |
2 |
|
cardiac differentiation, cardiac hypertrophic signals, embryonic stem cells |
2 |
|
cardiac dysfunction, lipid metabolism, metabolic hormones, mitochondrial dysfunction, physical exercise |
2 |
|
cardiac fibroblasts, cardiac regeneration, induced pluripotent stem cells |
2 |
|
cardiac infarction, induced pluripotent stem cells, mesenchymal stem cells, transplantation |
2 |
|
cardiac protection, induced pluripotent stem cells, mesenchymal stem cells, myocardiac differentiation, paracrine mechanisms |
2 |
|
cardiac rhythm management, wireless powered miniature pacing devices |
2 |
|
cardiovascular complications, chemiluminescent immunoassays for diabetes |
2 |
|
cardiovascular disease, embryos, expanded potential stem cells, haploid, pluripotency |
2 |
|
cardiovascular risk, glucose |
2 |
|
cd14, chronic kidney disease, kidney fibrosis, kidney inflammation, tubular epithelial cells |
2 |
|
cd14, lbp, lipopolysaccharide, lupus nephritis, renal inflammation |
2 |
|
cd44, fibrosis, inflammation, lupus nephritis |
2 |
|
cell-derived, exploring, induced, pluripotent, role, stem |
2 |
|
cellular, chronic, failure, kidney, lupus, nephritis |
2 |
|
chemokine, glomerulo-nephritides, interstitial nephritis, tubulo-glomerular |
2 |
|
chemokine/chemokine receptor, iga nephropathy, leukocyte infiltration, progressive renal failure, tubulointerstitium |
2 |
|
chemotherapy, immunotherapy, lenvetinib, mutation, non-small cell lung cancer |
2 |
|
chinese, epidemiology, fracture, genetics, osteoporosis |
2 |
|
cholesterol homeostasis, ischemia stroke, oxidative stress |
2 |
|
chronic kidney disease, hyaluronan, interstitial fibroblasts, kidney fibrosis, proximal tubular epithelial cells |
2 |
|
chronic kidney disease, kidney inflammation, major vault protein, proximal tubular cells, tubulo-interstitial fibrosis |
2 |
|
chronic kidney disease, vitamin d deficiency |
2 |
|
chronic renal failure, endothelial progenitor cells, ppar-y |
2 |
|
chronic, illness, pcv, pneumococcal, ppv |
2 |
|
clinical trial, diabetic nephropathy, pilot study, traditional chinese |
2 |
|
coiled-coil-helix-coiled-coil-helix, diseases, domain, mitochondrial, obesity, protein |
2 |
|
colonic polyp, colonoscopy, colorectal cancer, randomised controlled trial |
2 |
|
comparative, elderly, lung cancer, pooled analysis |
2 |
|
comprehensive, ischemic stroke, magnetic resonance imaging, mri, transient ischemic attack |
2 |
|
dat, dopamine, dopamine homeostasis, dopamine turnover, parkinson's disease, syngr3 |
2 |
|
deciphering, mutation, myelodysplasia, recurrent, syndromes, therapeutic |
2 |
|
decorin, dialysis, fibrosis, inflammation, membrane, peritoneal |
2 |
|
decorin, fibrosis, inflammation, mesothelial cells, peritoneal dialysis |
2 |
|
dehydrogenase, extranodal, lactate, lymphoma, nk/t-cell, targeting |
2 |
|
del6q21, epigenetics, nasal nk/t-cell lymphoma, nk-cell malignancies, prdm1 |
2 |
|
diabetes |
2 |
|
diabetes mellitus, endothelial function, endothelial progenitor cells, periodontal disease, porphyromonas gingivalis |
2 |
|
diabetes, diabetic complications, endothelial dysfunction, nitric oxide, vascular disease |
2 |
|
diabetes, endothelial cells, ergothioneine, oxidative stress |
2 |
|
diabetes, gluconeogenesis, insulin resistance, liver, sbk1 |
2 |
|
diabetes, glucose metabolism, insulin, pancreatic beta cell functions, signal transduction |
2 |
|
diabetes, islet inflammation, macrophages, metabolic regulation, β-cell autoimmunity |
2 |
|
diabetes, lcn13, lipocalin, metabolic hormone, obesity |
2 |
|
diabetes, myocardial, necroptosis, rnlip, stat-3, stat-5a |
2 |
|
diabetic complications, hormones, nitric oxide, obesity, vascular disease |
2 |
|
diabetic nephropathy, gbm, hspg |
2 |
|
diagnosis, hospitalized, molecular, rapid, respiratory, tract |
2 |
|
diffusion mri, imaging, prediction, stroke |
2 |
|
direct |
2 |
|
dna |
2 |
|
drug target for cancer therapy, inhibitor of apoptosis protein, nmr spectroscopy, protein structure, protein-protein interaction |
2 |
|
drug testing and screening, isogenic ipscs, x-chromosome inactivation, xi-chromosome reactivation, x-linked cardiomyopathies |
2 |
|
drug testing, isogenic ipscs, mecp2 mutataion, prolonged qt interval, rett syndrome disease, sudden death |
2 |
|
dysregulation, interleukin-18, lupus, nephritis, neutrophils, receptor |
2 |
|
ebv, nasal nk/t-cell lymphomas, nl |
2 |
|
eda fibronectin, inflammation, kidney fibrosis, myofibroblasts, tubular epithelial cells |
2 |
|
eda fibronectin, mesothelial cells, peritoneal dialysis, peritoneal fibroblasts, peritoneal fibrosis |
2 |
|
embryonic stem cell, transplantation |
2 |
|
embryonic stem cells, survivin, zebrafish |
2 |
|
emt, mesothelial cells, mir-200c, peritoneal dialysis, peritoneal fibrosis |
2 |
|
endothelial senescence, herc2, lkb1, sirt1, vascular aging |
2 |
|
energy expenditure, obesity, sdc4 ectodomain, syndecan-4, white adipose tissue browning |
2 |
|
familial igan, glomerulonephritis, iga, igan, mesangial cell |
2 |
|
fat-derived hormones, metabolic syndrome, progressive atherosclerosis |
2 |
|
fibronectin, fibrosis, inflammation, mesothelial cells, peritoneal dialysis |
2 |
|
functional magnetic resonance, language deficits, stroke patients |
2 |
|
gastric adenocarcinoma, gastritis, intestinal metaplasia, microbiota |
2 |
|
gastronintestinal carcinogenesis, htert |
2 |
|
genetic polymorphism |
2 |
|
genetic, germline, mutation, optimal, paraganglioma, phaeochromocytoma |
2 |
|
gluconeogenesis, glucose metabolism, hormonal regulation, metabolic adaptation, metabolic diseases |
2 |
|
hbvdna |
2 |
|
hcc, metastasis, mouse model, notch inhibitor |
2 |
|
hcn channels, pacemaker, somatic gene, swine |
2 |
|
heart failure, induced pluripotent stem cells, myocardial infarction, placenta, tissue engineering |
2 |
|
heparan sulfate |
2 |
|
high-throughput screening, leukaemia, mpns, multi-colour, transgenesis, zebrafish |
2 |
|
hip fracture, osteoporosis, prediction, death, mortality |
2 |
|
hormones, novel fat-derived |
2 |
|
human polyomaviruses, respiratory tract |
2 |
|
iga nephropathy |
2 |
|
iga nephropathy, igan, renin-angiotensin, tubulointerstitial |
2 |
|
iga nephropathy, mesangial cells, polymeric iga |
2 |
|
iga, iga1, nephropathy, pathogenesis |
2 |
|
immunoglobulin |
2 |
|
immunological response, longitudinal seroepidemiology |
2 |
|
in vitro study, nasal brushing, rimary nasal epithelial cells |
2 |
|
inducible degrader of ldlr, ldl receptor, macrophage, type 2 diabetes, zebrafish |
2 |
|
inflammasomes, microrna, regulatory mechanism, systemic lupus erythematosus |
2 |
|
interleukin-17 |
2 |
|
intramyocellular lipid, magnetic resonance imaging, mr diffusion, mr spectroscopy, mri |
2 |
|
jak2v617f, myeloproliferative disease, nod/scid mice, polycythemia vera, transplantation |
2 |
|
keyword |
2 |
|
l-arginine |
2 |
|
lung cancer, s-1 |
2 |
|
lupus nephritis, mesangial cell proliferation, mrl/1pr mice |
2 |
|
mesothelioma |
2 |
|
methylation, microrna, multiple myeloma, stem cell, tumor suppressor |
2 |
|
micrornas, plasmacytoid dendritic cells, systemic lupus erythematosus |
2 |
|
monocyte, neutrophil |
2 |
|
multiple sclerosis |
2 |
|
multiple sclerosis, neuroinflammation, neuromyelitis optica |
2 |
|
myocytes |
2 |
|
nephropathy |
2 |
|
nk/t-cell lymphoma, nl |
2 |
|
non-small cell lung cancer |
2 |
|
non-small cell lung cancer, sorafenib |
2 |
|
obesity |
2 |
|
p21, rheumatoid arthritis, systemic lupus erythematosus |
2 |
|
platform of human pluripotent stem cell-derived, tissue regeneration and industrial application |
2 |
|
provision |
2 |
|
stem cell |
2 |
|
1) dilated cardiomyopathy 2) cardiac laminopathy 3) lamin a/c 4) gene therapy 5)
rna therapeutics |
2 |
|
ageing, β-klotho, adipocyte, senescence |
2 |
|
appl2, neurogenesis, mitochondrial function, hyperglycaemia, stroke |
2 |
|
autoimmune diseases, multiple sclerosis, th17, sirtuin, histone acylations, posttranslational modifications |
2 |
|
bone marrow adipose tissue, hematopoiesis, type 2 immune response, cold-induced beiging, |
2 |
|
chronic kidney disease, annexin-a2, kidney inflammation, kidney fibrosis, emt |
2 |
|
chronic obstructive pulmonary disease, copd exacerbation, n-acetylcysteine, hospitalization |
2 |
|
continuous ambulatory peritoneal dialysis, automated peritoneal dialysis, cost effectiveness, end stage renal failure, mic evaluation |
2 |
|
elderly stroke, batokine, brown adipose tissue, |
2 |
|
hormones, insulin secretion, obesity , diabetes , metabolic regulation |
2 |
|
lupus nephritis, hyaluronan, inflammation, 4-methylumbelliferone, mycophenolate |
2 |
|
metabolic syndrome, inflammation, macrophages, obesity, fatty liver disease |
2 |
|
roles of oral microbiome bacteria in modulating pathogenicity of helicobacter pylori in infected population |
2 |
|
semaphorin 6b, glucose-lowering effect, type 2 diabetes, insulin sensitivity, gluconeogenesis |
2 |
|
single-cell multi-omics study |
2 |
|
sjogren's syndrome, ifnar1, ifn-i, t effector cell, b cell |
2 |
|
sjogren’s syndrome, t follicular helper, calycosin |
2 |
|
stroke, epac, blood brain barrier, cerebral small vessel disease, humans, mice |
2 |
|
3d-bioprinting, atrio-ventricular node, bio-artificial pacemaker, induced pluripotent stem cell |
1 |
|
ac-sdkp, animal models, fibrosis, inflammation, proteinuria |
1 |
|
acid, drug, lupus, mycophenolic, nephrities, therapeutic |
1 |
|
acids, circulating, fetal, nucleic |
1 |
|
acute kidney injury, animal models, chronic kidney disease, protease-activated receptor, regulatory mechanisms |
1 |
|
acute myeloid leukaemia, aml, detection and monitoring services, hong kong, minimal residual disease, mrd |
1 |
|
acute myeloid leukaemia, nucleophosmin 1, oral arsenic trioxide |
1 |
|
acute myeloid leukaemia, plk4, plk4 inhibitor, polo-like kinase 4, tp53, tumour protein p53 |
1 |
|
acute myeloid leukemia, flt3-itd, hematopoiesis, zebrafish |
1 |
|
acute myeloid leukemia, flt3-itd, olaparib, parp |
1 |
|
acute myeloid leukemia, hematopoietic stem cells, luekemia stem cells, sox7 |
1 |
|
acute myeloid leukemia, microglia, pu.1, suppressor/enhancer, zebrafish |
1 |
|
acute promyelocytic leukaemia, arsenic trioxide, resistance |
1 |
|
acute, decitabine, dnmt3a, leukemia, mutation, myeloid |
1 |
|
acute, develop, leukaemia, myeloid, personalized, throughput |
1 |
|
acute, identification, leukaemia, methylated, mirnas, promyelocytic |
1 |
|
adaptive immunity, dendritic cells, innate immune responses, mycobacterium tuberculosis, pathogen host interaction, t cells |
1 |
|
adiponectin |
1 |
|
adipose browning, androgen, prdm16 |
1 |
|
adipose tissue inflammation, sirt1, systemic insulin sensitivity |
1 |
|
adrenomedullin, adrenomedullin binding, cytokine, macrophages |
1 |
|
advanced dementia, aspiration pneumonia, assisted oral feeding, feeding problems, nasogastric tubes, survival |
1 |
|
advanced non-small cell lung cancer |
1 |
|
advances, disease, health, immunology |
1 |
|
age clearance receptors, oxidative stress, soluble rage |
1 |
|
akt, diabetes, glucose metabolsim, insulin resistance, signal transduction |
1 |
|
albumin-induced chemokine, hmg-coa reductase inhibitors, tubular epithelial cells |
1 |
|
aldehyde dehydrogenase, primitive hematopoiesis, zebrafish |
1 |
|
alk-driven cancers, anaplastic lymphoma kinase, arsenic trioxide, drug resistance, tyrosine kinase inhibitor |
1 |
|
aml, flt3, follistatin, itd |
1 |
|
an observational multicenter study, prognostic indicators, regional iga nephropathy |
1 |
|
animal model, aquaporin-4, autoantibodies, autoimmune diseases, neuromyelitis optica, t follicular helper cells |
1 |
|
animal models, chronic kidney disease, foxp2, regulatory mechanisms, transcription factor |
1 |
|
animal models, human kidney biopsy, kallistatin, kidney fibrosis, wnt/β-catenin signaling |
1 |
|
anti-depressant, effects, fgf21, mediator, physical, potential |
1 |
|
anti-inflammatory, chronic, combat, disease, kidney, platform |
1 |
|
apolipoprotein |
1 |
|
apoptosis, endothelium, nitrate tolerance, propofol |
1 |
|
arl4a, cord blood, definitive hematopoiesis, zebrafish |
1 |
|
arsenic trioxide, mesothelioma |
1 |
|
arsenic trioxide, non-small cell lung cancer |
1 |
|
asian women, low bone mass, postmenopausal |
1 |
|
asthma, diabetes, inhaled corticosteroids |
1 |
|
asthmatic patients, montelukast sodium |
1 |
|
atherosclerosis |
1 |
|
atherosclerosis, endothelial dysfunction, mitochondrial membrane, obesity, perivascular adipose, uncoupling protein 1 |
1 |
|
autoimmune diabetes, hyperglycemia, inflammation, insulin, islet beta-cells |
1 |
|
avail |
1 |
|
azacitidine, haematopoietic, leukaemia, myeloid, relapse, transplant |
1 |
|
b-catenin signaling, injury, renal ischemia-reperfusion |
1 |
|
biological cells, optical tweezers, robotic manipulation |
1 |
|
biological, leukaemia, myeloid, therapeutic, tp53-mutated, zebrafish |
1 |
|
biologics and biosimilars, cost-effectiveness, decision analytics, disease simulation model, healthcare big data |
1 |
|
biomarker, endothelial function, obesity/diabetes, physical exercise, shear stress/flow |
1 |
|
biomarkers |
1 |
|
biomarkers, clinical applications, lung cancer, mutations |
1 |
|
biomarkers, type 2 diabetes |
1 |
|
blood pressure, hypertensive cardiomyopathy, left ventricular remodeling, splanchnic denervation |
1 |
|
blood product, hsct, immunocompromised, occult hbv, sequencing, source of infection |
1 |
|
bone density of oral alendronate, placebo, postmenopausal women with osteoporosis |
1 |
|
bone marrow adipocyte, insulin sensitivity, mechano-sensitive ion channel, mesenchymal stem cell, osteoblast |
1 |
|
bone marrow, btbr ob/ob mice, dedifferentiation, diabetic nephropathy, podocytes, translational study |
1 |
|
bone morphogenetic protein-7, db/db mouse, diabetic nephropathy, inflammation and fibrosis, renal tubular cell |
1 |
|
bone, ginsenoside rg1, phytoestrogen, tissue selectivity, uterus |
1 |
|
ca2+ homeostasis, cardioprotection, kappa opioid receptor, metabolic inhibition |
1 |
|
cancer, cell, egfr, lung, mutations, plasma |
1 |
|
cardiac fibroblasts, cell proliferation, ion channels |
1 |
|
cardiomyocyte, cm, es |
1 |
|
cardiovascular disease, shenzhen-hong kong united network |
1 |
|
cell manipulation, cell mechanism, hematopoietic cells, leukemia, optical tweezers, robotics |
1 |
|
central nervous system, motor retardation, myeloid leukemia, zebrafish; microglia |
1 |
|
chemotherapy-induced nausea and vomiting |
1 |
|
chimeric rabbit model, familial hypercholesterolemia, generation, human liver |
1 |
|
chinese patients, insulin lispro versus humulin r |
1 |
|
chroic hepatitis b |
1 |
|
chronic kidney disease, coagulation system, kidney fibrosis, pharmacologic inhibition, protease-activated, renal tubular cells |
1 |
|
chronic lymphocytic leukaemia, gene mutation status, ighv (immunoglobulin heavy chain variable region) |
1 |
|
chronic myelomonocytic leukaemia (cmml), haematopoiesis, mutation combinations, therapeutic screening, zebrafish model |
1 |
|
chronic, fibronectin, hbsag, hepatitis, seroclearance, t cells |
1 |
|
clinical outcome, multiple sclerosis |
1 |
|
colorectal cancer |
1 |
|
complement 5a, complement 5a receptor, diabetic nephropathy, fibrosis, inflammation |
1 |
|
complications, diabetic, glycation end products |
1 |
|
conditional activation mice, protein overload, proximal tubular cells, renal fibrosis, wnt/beta-catenin signaling |
1 |
|
cultured tubular cells, kidney disease, knock out mice, lipid metabolism, mitochondrial dysfunction, translocator protein |
1 |
|
curative, leukemia, marrow, myeloid, refractory, sorafenib |
1 |
|
cyclooxygenase pathway, gastric cancer, helicobacter pylori |
1 |
|
cyclooxygenase, gastric cancer |
1 |
|
cytokine genes, molecular exploration, pathogenesis of iga |
1 |
|
db/db mouse, diabetic nephropathy, inflammation and fibrosis, kallikrein-kinin system, renal tubular cell |
1 |
|
dementia |
1 |
|
dendritic cell, lupus erythematosus, pathogenesis |
1 |
|
detection, egfr mutation, lung cancer, plasma dna |
1 |
|
detector |
1 |
|
diabete |
1 |
|
diabetes mellitus, soluble rage |
1 |
|
diabetes, energy metabolism, physical exercise, ppardelta, vascular function |
1 |
|
diabetes, glucose metabolism, insulin resistance, obesity, signal transduction |
1 |
|
diabetes, molecular mechanism, obestiy, therapeutic intervention, vascular dysfunction |
1 |
|
diabetic cardiomyopathy, exercise intervention, fibroblast growth factor 21, hormones, metabolic syndrome |
1 |
|
diabetic db/db mice, diabetic nephropathy, fibrosis, inflammation, ppar-γ agonist |
1 |
|
diabetic nephropathy, incrna nuclear enriched abundant, transcript 1 (neat1) |
1 |
|
diagnosis, machine learning, multi-omics, nafld, nash, prediction model |
1 |
|
dichloroacetate and niclosamide, inhibition of warburg, malignant pleural mesothelioma |
1 |
|
disease activity, disease damage, morbidity, mortality, systemic lupus |
1 |
|
disease modeling, induced pluripotent stem cells, targeted gene correction, wilson’s disease |
1 |
|
dna methylation, hottip, long non-coding rna, mantle cell lymphoma, prognosis, tumour suppressor |
1 |
|
dna, plasma |
1 |
|
double ballon, enterscopy, small bowel disease |
1 |
|
double transgenic mouse, renal inflammation, renal tubular cells, toll-like receptor-4, wnt/β-catenin |
1 |
|
echocardiography, pulmonary hypertension, screening, systemic lupus erythematosus |
1 |
|
egf/polyamine/k+, gastric mucosal repair |
1 |
|
establishment |
1 |
|
exacerbation |
1 |
|
exercise, exerkines, metabolomics, proteomics, randomized controlled trial, t2dm |
1 |
|
fatty, gut, liver, microbiota, non-alcoholic, targeting |
1 |
|
fatty, liver, non-alcoholic, obesity, protein-coupled, receptor |
1 |
|
fgf21, insulin resistance, microrna, obesity |
1 |
|
fish, mutiple myeloma |
1 |
|
free, generation, prognostic, provision, sequencing, service |
1 |
|
frontiers, immunometabolism |
1 |
|
functional dyspepsia, gastro-duodenal motility, gastrointestinal, hydrogen breath test |
1 |
|
gamma |
1 |
|
gastric cancer, helicobacter pylori infection |
1 |
|
gastric carcinogenesis, pylori-induced |
1 |
|
gene expression, rat anterior pituitary, vasoactive intestinal peptide |
1 |
|
gene methylation, mantle cell lymphoma, methylation profile, microrna, tumor suppressor |
1 |
|
genetic study, multiple myeloma, personalized, treatment |
1 |
|
glomerulonephritis, hormone, pathogenesis |
1 |
|
glucose metabolism, hormones, insulin secretion, metabolic disease, β-cell dysfunction |
1 |
|
hbsag carrier |
1 |
|
hbv, hbx, pin1 |
1 |
|
heart failure, hypertension, spinal cord stimulation |
1 |
|
heart failure, renal denervation |
1 |
|
hematopoiesis, hematopoietic stem cells, methionine aminopeptidase, zebrafish |
1 |
|
hepatitis |
1 |
|
hepatitis c |
1 |
|
hepatocytes, induced pluripotent stem cells, manufacture |
1 |
|
hypercholesterolaemia and nephropathy |
1 |
|
ibritumomab, lymphoma |
1 |
|
iymphoma |
1 |
|
jade |
1 |
|
kidney inflammation, long non-coding rna, single-cell deep sequencing, toll-like receptor 4, translatinal research |
1 |
|
kidney injury molecule, macrophages, regeneration, tim-4, tubular epithelial cell |
1 |
|
locally advanced nsclc, metastatic nsclc, recurrent nsclc |
1 |
|
locally-advanced, metastatic (stage iiib or iv) nsclc |
1 |
|
losartan renal protection |
1 |
|
lung carcinoma |
1 |
|
macrophages, myofibroblasts, organ fibrosis |
1 |
|
malignant pleural mesothelioma |
1 |
|
merit |
1 |
|
mesenchymal stem cells, methylation, myeloma, rankl |
1 |
|
minimal residual disease, multiple myeloma |
1 |
|
myeloid leukemia |
1 |
|
n/a |
1 |
|
novel biodegradable endoclip, endoscopic procedures |
1 |
|
oral gatifloxacin |
1 |
|
outstanding researcher award |
1 |
|
pf |
1 |
|
pluripotent stem cells, viral-vector integration-free |
1 |
|
pneumonia |
1 |
|
prevention and therapy in malignant pleural mesohelioma |
1 |
|
refer to hard copy, strait |
1 |
|
regulating expression of pai-i in renal fibrosis, the role of forkhead box p protein 2 (foxp2) |
1 |
|
sclerogenic cytokines, ultrafiltration failure |
1 |
|
sleep disorders |
1 |
|
stage iiib/v nsclc |
1 |
|
stage iiib/v or recurrent nsclc |
1 |
|
stroke |
1 |
|
sudden unexpected death |
1 |
|
th17, 糖尿病早期防治, 运动干预 |
1 |
|
transplantation |
1 |
|
非酒精性脂肪性肝病, 潘氏细胞, 肠道菌群 |
1 |
|
""biologics"", ""inflammatory"", ""bowel disease"" |
1 |
|
""mesothelioma"" |
1 |
|
aortic stenosis, empagliflozin, sglt2 inhibitor, , |
1 |
|
bcaas, adipose tissue, adam17, soluble il-6 receptor, insulin resistance |
1 |
|
clinical immunology,tumor immunology,autoimmunity,immune deficiency,infectious disease |
1 |
|
developing, next-generation synbiotic, treatment of metabolic dysfunction associated, fatty liver disease |
1 |
|
development, a rapid ambulatory kidney function assessment technology, electrical impedance tomography |
1 |
|
development, evidence-based, nutritional intervention, gut microbiota, athletic performance |
1 |
|
development, rapid ambulatory kidney function assessment technology, electrical impedance tomography |
1 |
|
efficacy, therapeutic, monoclonal, antibodies, autotaxin |
1 |
|
frontline oral arsenic, trioxide-based induction, newly diagnosed, acute promyelocytic leukaemia |
1 |
|
lung function assessment, electrical impedance tomography, lung cancer, uncommon lung diseases |
1 |
|
mafld, obesity, fatty liver disease, metabolic complications, biomarkers |
1 |
|
mitochondrial homeostasis, diabetic kidney disease, complement c5a/c5ar, kidney tubular cells, conditional knockout mice |
1 |
|
mobile health intervention, digital healthcare, intracerebral, hypertension |
1 |
|
neuromyelitis optica, aquaporin-4 autoantibodies, autoimmunity, b lymphocytes, bruton's tyrosine kinase |
1 |
|
next-generation synbiotic, treatment of metabolic dysfunction, associated fatty liver disease |
1 |
|
next-generation synbiotic,treatment, metabolic dysfunction, fatty liver disease |
1 |
|
rapid ambulatory kidney function, assessment technology, electrical impedance tomography |
1 |
